1. Home
  2. TILE vs AGIO Comparison

TILE vs AGIO Comparison

Compare TILE & AGIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Interface Inc.

TILE

Interface Inc.

HOLD

Current Price

$28.89

Market Cap

1.6B

ML Signal

HOLD

Logo Agios Pharmaceuticals Inc.

AGIO

Agios Pharmaceuticals Inc.

HOLD

Current Price

$27.42

Market Cap

1.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TILE
AGIO
Founded
1973
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Home Furnishings
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.7B
IPO Year
1994
2013

Fundamental Metrics

Financial Performance
Metric
TILE
AGIO
Price
$28.89
$27.42
Analyst Decision
Buy
Buy
Analyst Count
1
8
Target Price
$36.00
$38.88
AVG Volume (30 Days)
517.8K
709.3K
Earning Date
05-08-2026
04-29-2026
Dividend Yield
0.29%
N/A
EPS Growth
32.43
N/A
EPS
0.40
N/A
Revenue
$1,386,854,000.00
$43,011,000.00
Revenue This Year
$6.72
$76.75
Revenue Next Year
$5.61
$170.73
P/E Ratio
$71.95
N/A
Revenue Growth
5.41
N/A
52 Week Low
$20.01
$22.24
52 Week High
$35.11
$46.00

Technical Indicators

Market Signals
Indicator
TILE
AGIO
Relative Strength Index (RSI) 52.05 44.68
Support Level $26.60 $26.75
Resistance Level $28.89 $29.37
Average True Range (ATR) 1.02 1.21
MACD -0.02 -0.05
Stochastic Oscillator 58.14 21.03

Price Performance

Historical Comparison
TILE
AGIO

About TILE Interface Inc.

Interface Inc is engaged in the design, production, and sale of carpet tiles. It also provides Luxury Vinyl tiles and rubber flooring. The company mainly targets corporate and noncorporate office markets, including government, education, healthcare, hospitality, and retailers. Its geographical segments include the Americas, Europe, and Asia-Pacific. It has two operating and reportable segments- namely Americas (AMS) and Europe, Africa, Asia and Australia (collectively EAAA). Key revenue is generated from AMS segment. Its products include: ESD, Acoustic, Extreme Wear, and Quick Installation System (nTx).

About AGIO Agios Pharmaceuticals Inc.

Agios Pharmaceuticals Inc is a biopharmaceutical company focused on the field of cellular metabolism to create differentiated medicines for rare diseases, with a focus on classical hematology. The company's primary focus is to develop potentially transformative small-molecule medicines. Its product candidate, Pyrukynd (mitapivat), is an activator of both wild-type and mutant pyruvate kinase enzymes, developed for the treatment of hemolytic anemias. The other drug candidates in its pipeline include Tebapivat (PK activator), being developed as a potential treatment for MDS-associated anemia and sickle cell disease, AG-181 (PAH stabilizer), AG-236 and others.

Share on Social Networks: